Ibandronate Sodium | Aurobindo Pharma Limited Breastfeeding
American Academy of Pediatrics and other medical experts exclusively recommend to breastfeed the baby for first 6 months. Once you introduce baby to other foods it is recommended to breastfeed for at least first year of babys life. Taking medication while breastfeeding could be tricky as most drugs pass in breast milk. In this article we will evaluate Ibandronate Sodium | Aurobindo Pharma Limited for its safety in breastfeeding.

What is Ibandronate Sodium | Aurobindo Pharma Limited used for?


Ibandronate sodium is a bisphosphonate indicated for the treatment and prevention of postmenopausal osteoporosis. (1.1) Limitations of Use The optimal duration of use has not been determined. For patients at low -risk for fracture, consider drug discontinuation after 3 to 5 years of use. (1.2) 1.1 Treatment and Prevention of Postmenopausal Osteoporosis Ibandronate sodium tablets are indicated for the treatment and prevention of osteoporosis in postmenopausal women. Ibandronate sodium tablets increase bone mineral density (BMD) and reduce the incidence of vertebral fractures. 1.2 Important Limitations of Use The optimal duration of use has not been determined. The safety and effectiveness of ibandronate sodium tablets for the treatment of osteoporosis are based on clinical data of three years duration. All patients on bisphosphonate therapy should have the need for continued therapy re-evaluated on a periodic basis. Patients at low-risk for fracture should be considered for drug discontinuation after 3 to 5 years of use. Patients who discontinue therapy should have their risk for fracture re-evaluated periodically.

I am currently breastfeeding and I want to know if using Ibandronate Sodium | Aurobindo Pharma Limited is safe for my kid? Does it have any effect on milk production?

Ibandronate Sodium | Aurobindo Pharma Limited low risk for breastfeeding
Ibandronic acid is the one and only active ingredient present in Ibandronate Sodium | Aurobindo Pharma Limited. Ibandronic acid in itself is a low risk drug for lactation so it is easy to understand that Ibandronate Sodium | Aurobindo Pharma Limited also comes in category of Low Risk item while breastfeeding. Below is the summary of Ibandronic acid in breastfeeding.

Ibandronate Sodium | Aurobindo Pharma Limited Breastfeeding Analsys


Ibandronic acid while Breastfeeding

Low Risk

CAS Number: 114084-78-5

It is composed by bisphosphonates. Most bisphosphonates are acidic compounds that achieve low plasma concentration. Both features make it unlikely excretion into the milk in clinically significant amount. Intestinal absorption of bisphosphonates is very low even during fasting and is considered negligible in the presence of milk due to formation with the calcium of non absorbable compounds. Among bisphosponate preparations, Tiludronate and Zoledronate have the longest half-lives period of elimination and thus they are the less indicated to take while breastfeeding. A latest update no published data were found on excretion in the breast milk. Until more data about this drug regarding breastfeeding is available, safer known alternatives (pamidronate) should be of choice, especially in the neonatal period and in case of prematurity.

Ibandronate Sodium | Aurobindo Pharma Limited Breastfeeding Analsys - 2


Ibandronic acid while Breastfeeding

CAS Number: 114084-78-5

IBecause no information is available on the use of ibandronate during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant. However, absorption of ibandronate by a breastfed infant is unlikely.


I already used Ibandronate Sodium | Aurobindo Pharma Limited and meanwhile I breastfed my baby should I be concerned?

During whole lactation period you shall first discuss with your doctor and then together you shall decide whether you shall take that drug or not however if you have already taken Ibandronate Sodium | Aurobindo Pharma Limited then you shall inform your doctor, But you should not be worried too much as Ibandronate Sodium | Aurobindo Pharma Limited comes in category of low risk drug.


My health care provider has asked me to use Ibandronate Sodium | Aurobindo Pharma Limited, what to do?

Though Ibandronate Sodium | Aurobindo Pharma Limited dose not comes in category of safe drugs rather it comes in category of low risk but if your doctor is aware that you are breastfeeding your baby and has still recommended it then its advantages must be outweighing the risks.


If I am using Ibandronate Sodium | Aurobindo Pharma Limited, will my baby need extra monitoring?

Not much


Who can I talk to if I have questions about usage of Ibandronate Sodium | Aurobindo Pharma Limited in breastfeeding?

US
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday

UK
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700

Australia
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week

Canada
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week